IGF-1 promotes the development and cytotoxic activity of human NK cells

Nature Communications

Volumn 4, Issue , 2013, Pages

  Ni, Fang ^a,b   Sun, Rui ^a   Fu, Binqing ^a,c   Wang, Fuyan ^a   Guo, Chuang ^a   Tian, Zhigang ^a,c   Wei, Haiming ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; SOMATOMEDIN C;

ANTIBODY; CYTOLOGY; FUNCTIONAL ROLE; GENE EXPRESSION; GROWTH REGULATOR; HOMINID; HORMONE; IMMUNITY; INNATE BEHAVIOR; PHYSIOLOGY; TOXICOLOGY;

ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; NATURAL KILLER CELL; NEWBORN; SELECTIVE ABORTION; UMBILICAL CORD BLOOD;

3' UNTRANSLATED REGIONS; ANTIGENS, CD34; BASE SEQUENCE; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CYTOTOXICITY, IMMUNOLOGIC; FETAL BLOOD; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MICRORNAS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RNA, MESSENGER; SUBCELLULAR FRACTIONS;

EID: 84874613436     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2484     Document Type: Article

References (47)

1. Di Santo, J. P. Natural killer cell developmental pathways: a question of balance. Annu. Rev. Immunol. 24, 257-286 (2006)
2. Vivier, E., Tomasello, E., Baratin, M., Walzer, T. & Ugolini, S. Functions of natural killer cells. Nat. Immunol. 9, 503-510 (2008) (Pubitemid 351560519)
3. Smyth, M. J., Hayakawa, Y., Takeda, K. & Yagita, H. New aspects of naturalkiller-cell surveillance and therapy of cancer. Nat. Rev. Cancer 2, 850-861 (2002) (Pubitemid 37328903)
4. Lodoen, M. B. & Lanier, L. L. Natural killer cells as an initial defense against pathogens. Curr. Opin. Immunol. 18, 391-398 (2006) (Pubitemid 43947576)
5. Fehniger, T. A. et al. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity 26, 798-811 (2007) (Pubitemid 46907665)
6. Kägi, D. et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369, 31-37 (1994) (Pubitemid 24144352)
7. Russell, J. H. & Ley, T. J. Lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 20, 323-370 (2002) (Pubitemid 34293428)
8. Grossman, W. J. et al. The orphan granzymes of humans and mice. Curr. Opin. Immunol. 15, 544-552 (2003) (Pubitemid 37130195)
9. Lanier, L. L., Le, A. M., Civin, C. I., Loken, M. R. & Phillips, J. H. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J. Immunol. 136, 4480-4486 (1986) (Pubitemid 16090665)
10. Fehniger, T. A. et al. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 101, 3052-3057 (2003) (Pubitemid 36857995)
11. Fontenot, J. D., Rasmussen, J. P., Gavin, M. A. & Rudensky, A. Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6, 1142-1151 (2005) (Pubitemid 41541792)
12. Koopman, L. A. et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J. Exp. Med. 198, 1201-1212 (2003) (Pubitemid 37323385)
13. Ferlazzo, G. et al. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol. 172, 1455-1462 (2004) (Pubitemid 38116788)
14. Bryceson, Y. T. et al. Functional analysis of human NK cells by flow cytometry. Methods Mol. Biol. 612, 335-352 (2010)
15. Cooper, M. A. et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56 (bright) subset. Blood 97, 3146-3151 (2001)
16. O'Connor, J. C. et al. Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology. Cell Immunol. 252, 91-110 (2008)
17. Merchav, S., Tatarsky, I. & Hochberg, Z. Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor-1/somatomedin C and human growth hormone. J. Clin. Invest. 81, 791-797 (1988) (Pubitemid 18079727)
18. Aron, D. C. Insulin-like growth factor-1 and erythropoiesis. Biofactors 3, 211-216 (1992)
19. Stuart, C. A., Meehan, R. T., Neale, L. S., Cintron, N. M. & Furlanetto, R. W. Insulin-like growth factor-I binds selectively to human peripheral blood monocytes and B-lymphocytes. J. Clin. Endocrinol. Metab. 72, 1117-1122 (1991) (Pubitemid 21921816)
20. Kooijman, R. et al. Expression of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells. Endocrinol. 131, 2244-2250 (1992)
21. Badolato, R. et al. Differential expression of surface membrane growth hormone receptor on human peripheral blood lymphocytes detected by dual fluorochrome flow cytometry. J. Clin. Endocrinol. Metab. 79, 984-990 (1994) (Pubitemid 24342235)
22. Wendt, K. et al. Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells. J. Leukoc. Biol. 80, 1529-1541 (2006) (Pubitemid 44904992)
23. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004)
24. Kim, T. D. et al. Human microRNA-27a targets Prf1 and GzmB expression to regulate NK-cell cytotoxicity. Blood 118, 5476-5486 (2011)
25. Huang, Y. et al. MicroRNA regulation of STAT4 protein expression: rapid and sensitive modulation of IL-12 signaling in human natural killer cells. Blood 118, 6793-6802 (2011)
26. Cichocki, F. et al. Cutting edge: microRNA-181 promotes human NK cell development by regulating Notch signaling. J. Immunol. 187, 6171-6175 (2011)
27. Bezman, N. A., Chakraborty, T., Bender, T. & Lanier, L. L. miR-150 regulates the development of NK and iNKT cells. J. Exp. Med. 208, 2717-2731 (2011)
28. Sullivan, R. P. et al. MicroRNA-deficient NK cells exhibit decreased survival but enhanced function. J. Immunol. 188, 3019-3030 (2012)
29. Trotta, R. et al. miR-155 regulates IFN-g production in natural killer cells. Blood 119, 3478-3485 (2012)
30. Heemskerk, V. H., Daemen, M. A. & Buurman, W. A. Insulin-like growth factor-1 (IGF-1) and growth hormone (GH) in immunity and inflammation. Cytokine Growth Factor Rev. 10, 5-14 (1999) (Pubitemid 29230848)
31. Frostad, S., Bjerknes, R., Abrahamsen, J. F., Olweus, J. & Bruserud, O. Insulinlike growth factor-1 (IGF-1) has a costimulatory effect on proliferation of committed progenitors derived from human umbilical cord CD34 cells. Stem Cells 16, 334-342 (1998) (Pubitemid 28455649)
32. Orkin, S. H. & Zon, L. I. Hematopoiesis: an evolving paradigm for stem cell biology. Cell 132, 631-644 (2008) (Pubitemid 351260057)
33. Gascoyne, D. M. et al. The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nat. Immunol. 10, 1118-1124 (2009)
34. Yokota, Y. et al. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397, 702-706 (1999)
35. White, M. F. The IRS-signalling system: a network of docking proteins that mediate insulin action. Mol. Cell. Biochem. 182, 3-11 (1998) (Pubitemid 28181643)
36. Baserga, R. The contradictions of the insulin-like growth factor 1 receptor. Oncogene 19, 5574-5581 (2000)
37. Valentinis, B. et al. Growth and differentiation signals by the insulin-like growth factor 1 receptor in hemopoietic cells are mediated through different pathways. J. Biol. Chem. 274, 12423-12430 (1999)
38. Bryceson, Y. T., March, M. E., Barber, D. F., Ljunggren, H. G. & Long, E. O. Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J. Exp. Med. 202, 1001-1012 (2005) (Pubitemid 41396899)
39. Yu, C. R. et al. Role of a STAT binding site in the regulation of the human perforin promoter. J. Immunol. 162, 2785-2790 (1999)
40. Baltimore, D. et al. MicroRNAs: new regulators of immune cell development and function. Nat. Immunol. 9, 839-845 (2008) (Pubitemid 352038302)
41. Lewis, B. P., Shih, I. H., Jones-Rhoades, M. W., Bartel, D. P. & Burge, C. B. Prediction of mammalian microRNA targets. Cell 115, 787-798 (2003) (Pubitemid 38058492)
42. Kamizono, S. et al. Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo. J. Exp. Med. 206, 2977-2986 (2009)
43. Bidlingmaier, M., Auernhammer, C. J., Feldmeier, H. & Strasburger, C. J. Effects of growth hormone and insulin-like growth factor I binding to natural killer cells. Acta Paediatr. Suppl. 423, 80-81 (1997) (Pubitemid 27511896)
44. Pollak, M. N., Schernhammer, E. S. & Hankinson, S. E. Insulin-like growth factors and neoplasia. Nat. Rev. Cancer. 4, 505-518 (2004) (Pubitemid 38868620)
45. Veronese, A. et al. Oncogenic role of miR-483-3p at the IGF2/483 locus. Cancer Res. 70, 3140-3149 (2010)
46. Nakamura, O., Hondo, E., Namba, Y. & Kiso, Y. IGF-I overexpression causes fetal loss during placentation in mice. J. Reprod. Dev. 50, 375-380 (2004) (Pubitemid 40631813)
47. Lee, S. H. et al. RasGRP1 is required for human NK cell function. J. Immunol. 183, 7931-7938 (2009).